This article represents the proceedings of a symposium held at the 2001 RSA meeting in Montreal, Canada. The organizer and chair was Barbara A. Flannery and the discussant was Raye Z. Litten. The presentations were (1) The use of biomarkers in alcohol-dependence treatment trials, by John P. Allen; (2) Strategies for enhancing patient compliance in clinical treatment trials, by Helen M. Pettinati; (3) The predictive utility of an alcohol-craving measure, by Barbara A. Flannery; (4) What should be the primary outcome measures in a clinical trial, by Damaris J. Rohsenow; (5) Innovative strategies for assessing functional outcomes in alcoholism treatment clinical trials, by Ron A. Cisler.
Using acquired knowledge and new technologies in alcoholism treatment trials
Flannery, B., Allen, JP., Pettinati, HM., Rohsenow, DJ., Cisler, RA., & Litten, RZ. (2002). Using acquired knowledge and new technologies in alcoholism treatment trials. Alcoholism, Clinical and Experimental Research, 26(3), 423-429. https://doi.org/10.1111/j.1530-0277.2002.tb02556.x